Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Patient Blood Management in Gynecologic Cancer
NCT05669872Not yet recruiting
- Sponsor
- Asan Medical Center
- Start
- Feb 2023
- Primary completion
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of ferric carboxymaltose in anemia (2 arms), sponsored by Asan Medical Center. Primary endpoint: Transfusion Rate at 3 weeks. Planned start Feb 2023; status: not yet recruiting.
02
Drugs
ferric carboxymaltose
03
Conditions
anemia
Beyond the preview
Go deeper on NCT05669872.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05669872.